The tweet was deleted by the author.
But we saved everything 🙂.
A social post unaffiliated with Becton Dickinson described the BD CentroVena One catheter as designed to streamline workflow with clinician input. Becton Dickinson stock is down 1.1% on the day at $185.43.
A social media account unaffiliated with Becton Dickinson highlighted the new BD CentroVena One catheter, designed to simplify workflow and support patient care. The post credits clinician insight and co-creation as key to the development of the device. The company operates in the medical instruments and supplies sector.
View post on X Loading...
Price broke under the weekly low at $186.49 and is setting a new low for the week. The stock is currently holding just above support from the MA-20 and remains positioned above the MA-20, MA-50, and MA-200, keeping the broader daily structure bullish. RSI at 64.6 is nearing overbought territory, suggesting the recent advance could be getting stretched.
Traders should watch for a close above $186.49 to indicate whether buyers will follow through. Over the past week, shares have seen a sustained move lower with a firm trend. Even so, the outlook for the coming trading week shows more than 80% probability of upside and less than 20% probability of downside, with an expected range of $183.18 to $187.67. A drop below $185.26 would show the move is being faded. On the weekly chart the longer-term picture stays constructive.
Earlier, analysts noted that Becton Dickinson shares maintained a broadly bullish structure as they consolidated near resistance levels. With the stock now testing support after a move lower, traders should focus on whether a recovery above $186.49 materializes to confirm sustained upward momentum.